2019 AAO临床指南:糖尿病视网膜病变

2019-10-01 美国眼科学会 AAO官网

2019年10月,美国眼科学会(AAO)发布了糖尿病视网膜病变指南,糖尿病视网膜病变是1型以及2型糖尿病常见并发症,是糖尿病患者终末器官病变的眼部表现,本文主要针对糖尿病视网膜病变的管理提供指导。

中文标题:

2019 AAO临床指南:糖尿病视网膜病变

英文标题:

Diabetic Retinopathy PPP 2019

发布机构:

美国眼科学会

发布日期:

2019-10-01

简要介绍:

2019年10月,美国眼科学会(AAO)发布了糖尿病视网膜病变指南,糖尿病视网膜病变是1型以及2型糖尿病常见并发症,是糖尿病患者终末器官病变的眼部表现,本文主要针对糖尿病视网膜病变的管理提供指导。

 

拓展指南:视网膜相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 AAO临床指南:糖尿病视网膜病变)] GetToolGuiderByIdResponse(projectId=1, id=2e9de1c0018530ea, title=2019 AAO临床指南:糖尿病视网膜病变, enTitle=Diabetic Retinopathy PPP 2019, guiderFrom=AAO官网, authorId=null, author=, summary=2019年10月,美国眼科学会(AAO)发布了糖尿病视网膜病变指南,糖尿病视网膜病变是1型以及2型糖尿病常见并发症,是糖尿病患者终末器官病变的眼部表现,本文主要针对糖尿病视网膜病变的管理提供指导。 , cover=, journalId=null, articlesId=null, associationId=134, associationName=美国眼科学会, associationIntro=AAO提供眼科的指南很多,网站提供全文; clinical statement中也是需要的指南。, copyright=0, guiderPublishedTime=Tue Oct 01 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年10月,美国眼科学会(AAO)发布了糖尿病视网膜病变指南,糖尿病视网膜病变是1型以及2型糖尿病常见并发症,是糖尿病患者终末器官病变的眼部表现,本文主要针对糖尿病视网膜病变的管理提供指导。 </P> <P> </P>拓展指南:<strong>与<font color=red>视网膜</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=802c41c00182e83d" title="2019 AAO临床指南:视网膜静脉阻塞" target=_blank>2019 AAO临床指南:视网膜静脉阻塞</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=baf2b1c001e93290" title="儿童视网膜母细胞瘤诊疗规范(2019 年版)" target=_blank>儿童视网膜母细胞瘤诊疗规范(2019 年版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=839511c00168a411" title="玻璃体内注射技术规范——2018 年欧洲视网膜专家学会共识解读" target=_blank>玻璃体内注射技术规范——2018 年欧洲视网膜专家学会共识解读</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=f6de81c001652237" title="2018 丹麦循证指南:糖尿病视网膜病变的筛查" target=_blank>2018 丹麦循证指南:糖尿病视网膜病变的筛查</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=658831c0015a4e96" title="我国糖尿病视网膜病变筛查的图像采集及阅片指南(2017年)" target=_blank>我国糖尿病视网膜病变筛查的图像采集及阅片指南(2017年)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E8%A7%86%E7%BD%91%E8%86%9C" target=_blank>有关视网膜更多指南</a></ul>, tagList=[TagDto(tagId=6678, tagName=糖尿病视网膜病变)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=32, categoryName=眼科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=24481, appHits=758, showAppHits=53, pcHits=6374, showPcHits=22041, likes=61, shares=52, comments=28, approvalStatus=1, publishedTime=Wed Jan 22 21:42:59 CST 2020, publishedTimeString=2019-10-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Jan 22 21:42:59 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:13:07 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 AAO临床指南:糖尿病视网膜病变)])
2019 AAO临床指南:糖尿病视网膜病变
下载请点击:
评论区 (19)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1198686, encodeId=4d941198686e3, content=收到, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Wed Mar 02 13:05:18 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065482, encodeId=0d4e106548239, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85c25681141, createdName=ms6000001942340332, createdTime=Sun Oct 31 10:24:31 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063156, encodeId=2cea1063156ce, content=受益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210418/cc6c8866d20e4edd87cec3e0f30aa3bc/34858b66bcdc47199de9bd40867070bf.jpg, createdBy=85be5481807, createdName=要加油, createdTime=Sat Oct 23 12:30:49 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058998, encodeId=fb1110589986a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=02603403809, createdName=黑咖, createdTime=Sat Oct 09 17:01:59 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054176, encodeId=78bc10541e6ab, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/054af7e2c85a4f638d73763538b715b5/c34bbb0dfc1e4a23970375db66a93932.jpg, createdBy=13f31416204, createdName=wxbpaul, createdTime=Thu Sep 23 15:54:12 CST 2021, time=2021-09-23, status=1, ipAttribution=)]
    2022-03-02 245462683

    收到

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1198686, encodeId=4d941198686e3, content=收到, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Wed Mar 02 13:05:18 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065482, encodeId=0d4e106548239, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85c25681141, createdName=ms6000001942340332, createdTime=Sun Oct 31 10:24:31 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063156, encodeId=2cea1063156ce, content=受益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210418/cc6c8866d20e4edd87cec3e0f30aa3bc/34858b66bcdc47199de9bd40867070bf.jpg, createdBy=85be5481807, createdName=要加油, createdTime=Sat Oct 23 12:30:49 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058998, encodeId=fb1110589986a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=02603403809, createdName=黑咖, createdTime=Sat Oct 09 17:01:59 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054176, encodeId=78bc10541e6ab, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/054af7e2c85a4f638d73763538b715b5/c34bbb0dfc1e4a23970375db66a93932.jpg, createdBy=13f31416204, createdName=wxbpaul, createdTime=Thu Sep 23 15:54:12 CST 2021, time=2021-09-23, status=1, ipAttribution=)]
    2021-10-31 ms6000001942340332

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1198686, encodeId=4d941198686e3, content=收到, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Wed Mar 02 13:05:18 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065482, encodeId=0d4e106548239, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85c25681141, createdName=ms6000001942340332, createdTime=Sun Oct 31 10:24:31 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063156, encodeId=2cea1063156ce, content=受益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210418/cc6c8866d20e4edd87cec3e0f30aa3bc/34858b66bcdc47199de9bd40867070bf.jpg, createdBy=85be5481807, createdName=要加油, createdTime=Sat Oct 23 12:30:49 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058998, encodeId=fb1110589986a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=02603403809, createdName=黑咖, createdTime=Sat Oct 09 17:01:59 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054176, encodeId=78bc10541e6ab, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/054af7e2c85a4f638d73763538b715b5/c34bbb0dfc1e4a23970375db66a93932.jpg, createdBy=13f31416204, createdName=wxbpaul, createdTime=Thu Sep 23 15:54:12 CST 2021, time=2021-09-23, status=1, ipAttribution=)]
    2021-10-23 要加油

    受益了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1198686, encodeId=4d941198686e3, content=收到, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Wed Mar 02 13:05:18 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065482, encodeId=0d4e106548239, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85c25681141, createdName=ms6000001942340332, createdTime=Sun Oct 31 10:24:31 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063156, encodeId=2cea1063156ce, content=受益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210418/cc6c8866d20e4edd87cec3e0f30aa3bc/34858b66bcdc47199de9bd40867070bf.jpg, createdBy=85be5481807, createdName=要加油, createdTime=Sat Oct 23 12:30:49 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058998, encodeId=fb1110589986a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=02603403809, createdName=黑咖, createdTime=Sat Oct 09 17:01:59 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054176, encodeId=78bc10541e6ab, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/054af7e2c85a4f638d73763538b715b5/c34bbb0dfc1e4a23970375db66a93932.jpg, createdBy=13f31416204, createdName=wxbpaul, createdTime=Thu Sep 23 15:54:12 CST 2021, time=2021-09-23, status=1, ipAttribution=)]
    2021-10-09 黑咖

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1198686, encodeId=4d941198686e3, content=收到, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Wed Mar 02 13:05:18 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065482, encodeId=0d4e106548239, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85c25681141, createdName=ms6000001942340332, createdTime=Sun Oct 31 10:24:31 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063156, encodeId=2cea1063156ce, content=受益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210418/cc6c8866d20e4edd87cec3e0f30aa3bc/34858b66bcdc47199de9bd40867070bf.jpg, createdBy=85be5481807, createdName=要加油, createdTime=Sat Oct 23 12:30:49 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058998, encodeId=fb1110589986a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=02603403809, createdName=黑咖, createdTime=Sat Oct 09 17:01:59 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054176, encodeId=78bc10541e6ab, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/054af7e2c85a4f638d73763538b715b5/c34bbb0dfc1e4a23970375db66a93932.jpg, createdBy=13f31416204, createdName=wxbpaul, createdTime=Thu Sep 23 15:54:12 CST 2021, time=2021-09-23, status=1, ipAttribution=)]
    2021-09-23 wxbpaul

    好的

    0